LXEO SCHEDULE 13G/A: SEC filing
Vestal Point Capital, LP
Filed with the SEC on · accession 0000902664-26-004577
LXEO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Vestal Point Capital, LP filed an amended Schedule 13G reporting beneficial ownership of 5,187,302 shares (6.3%) of Lexeo Therapeutics common stock, including 867,302 shares issuable upon exercise of warrants. The stock moved +12.5% by the first close after the filing.
Summary of the filing
Vestal Point Capital, LP filed an amended Schedule 13G reporting beneficial ownership of 5,187,302 shares (6.3%) of Lexeo Therapeutics common stock, including 867,302 shares issuable upon exercise of warrants. The filing is a passive investment position.
Key details
How LXEO stock reacted
Close before
$2.87
Nov 13, 2026
First close after
+12.54%
$3.23
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for LXEO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LXEO?
Click hereFrequently asked questions
What did LXEO file with the SEC on Nov 16, 2026?
LXEO filed a SCHEDULE 13G/A (SEC filing). Vestal Point Capital, LP filed an amended Schedule 13G reporting beneficial ownership of 5,187,302 shares (6.3%) of Lexeo Therapeutics common stock, including 867,302 shares issuable upon exercise of warrants. The filing is a passive investment position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did LXEO stock react to this filing?
LXEO closed at $2.87 before the filing and $3.23 on Nov 16, 2026 (+12.54%).
Other LXEO SEC filings
- 8-K · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 10-Q · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 13, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- EFFECT · SEC filingNov 4, 2026
- S-3 · Shelf registrationOct 29, 2026
Get alerts when LXEO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days